Indeed, IGF1R inhibition has been associated with decreased neuroblastoma cell growth and shown potent anti-tumor effects (Guerreiro et al., 2006; Tanno et al., 2006; Van den Eynden et al., 2018; Zhao et al., 2015). Here, IGF1R is linked to neuroblastoma.